ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 47 filers reported holding ORCHARD THERAPEUTICS PLC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $683 | -99.9% | 1,842,280 | -27.3% | 0.00% | -50.0% |
| Q3 2022 | $1,268,000 | +9.3% | 2,535,439 | +27.6% | 0.00% | +100.0% |
| Q2 2022 | $1,160,000 | +100.0% | 1,986,288 | +144.0% | 0.00% | 0.0% |
| Q1 2022 | $580,000 | -55.0% | 814,025 | -16.6% | 0.00% | -50.0% |
| Q4 2021 | $1,288,000 | -47.4% | 976,005 | -8.3% | 0.00% | -33.3% |
| Q3 2021 | $2,448,000 | +457.6% | 1,064,379 | +964.4% | 0.00% | +200.0% |
| Q2 2021 | $439,000 | -41.3% | 100,000 | -42.2% | 0.00% | 0.0% |
| Q4 2020 | $748,000 | +358.9% | 173,073 | +337.7% | 0.00% | – |
| Q3 2020 | $163,000 | -95.7% | 39,540 | -93.7% | 0.00% | -100.0% |
| Q2 2020 | $3,782,000 | +95.3% | 630,400 | +145.1% | 0.00% | +50.0% |
| Q1 2020 | $1,937,000 | +494.2% | 257,200 | +985.2% | 0.00% | – |
| Q4 2019 | $326,000 | – | 23,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 5,307,751 | $3,101,000 | 1.18% |
| TANG CAPITAL MANAGEMENT LLC | 2,000,000 | $1,168,000 | 0.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $4,060,000 | 0.08% |
| Artal Group S.A. | 1,803,858 | $1,054,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 616,402 | $360,000 | 0.05% |
| RA Capital Management | 3,040,885 | $1,776,000 | 0.05% |
| Forefront Analytics, LLC | 92,641 | $58,000 | 0.03% |
| Temasek Holdings (Private) Ltd | 4,319,049 | $2,523,188 | 0.01% |
| FEDERATED HERMES, INC. | 8,309,859 | $4,853,000 | 0.01% |
| Cormorant Asset Management, LP | 256,649 | $150,000 | 0.01% |